Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CovalonGuard** is a Covalon antimicrobial disinfectant and sanitizer product line rather than a single molecular drug entity. Publicly available information identifies at least two distinct products under this name: a **topical hand sanitizer spray** using **benzalkonium chloride** as the antimicrobial active, and a **hard-surface disinfectant solution** using **benzalkonium chloride plus didecyl dimethyl ammonium chloride**. The products were commercialized by **Covalon Technologies** around 2020, with Canada listings indicating approved disinfectant products and external distributor materials describing sustained antimicrobial barrier activity. Because the queried name maps to multiple specific formulations with different compositions and use settings, it is best treated as a non-specific branded disinfectant/sanitizer family rather than a single pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CovalonGuard.